×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!

Neurodegenerative Diseases: Studying protein aggregation using NanoTemper instruments

Neurodegenerative diseases like Alzheimer’s or Parkinson’s Disease affect millions of people worldwide. Although current treatments may help relieve some of the physical or mental symptoms, there is still no way to slow disease progression and no known cures. NanoTemper is committed to providing new solutions for studying these diseases and developing new treatments. This webinar will show how aggregation of intrinsically disordered proteins is a common characteristic of all neurodegenerative disorders and also how NanoTemper’s instruments can overcome the challenges of other technologies when studying them.

Previous Article
3 big takeaways from SLAS on the future of automation and screening
3 big takeaways from SLAS on the future of automation and screening

5,200 researchers, representing all of life sciences, gathered in San Diego in late January to discuss the ...

Up next
When aptamers are the better choice over mAbs
When aptamers are the better choice over mAbs

Monoclonal antibodies (mAbs) have become the molecule of choice when highly specific molecular recognition ...

Have a question about Dianthus?

Contact Specialist